Title of the paper is: An Evidence Based Policy Analysis of Prescription Cost Reductions in Medicare Part D after the Bipartisan Budget Act of 2018 and other policy initiatives that aim to reduce prescription pricing set by PhRMA post ACA. Time frame for paper is between: 2012-2019 Areas to be covered: 1. Analysis of Key Stakeholders A. The Players The main stakeholders involved, special interest groups, organizations, policymakers, media, and other key actors. Includes assessment of special interest groups, organizations, policymakers, media, and other key actors. A. The Advocates and the Critics To ensure policy effectiveness, what, if any, previous policy options have addressed the problem? Have they been effective? What gaps exist that need to be addressed? Identify supportive stakeholders (advocates) and individuals/groups opposing the policy (critics) and the reasons for their positions. B. Stakeholder Resources and Influence The objective, how strong is support/opposition? What resources are stakeholders able and willing to devote to supporting their position? Are stakeholders able to influence key policymakers? 2. Policy Development A. Policy Objectives Multiple co-variance matrices tend to overestimate the weight of outliers, developing policy solutions: What specific needs must be addressed? What policy goals/objectives will address the problem? B.A Policy Evaluation The three interventions proposed? What, if any, previous policy options have addressed the problem? Have they been effective? What gaps exist that need to be addressed? Evaluating political circumstances surrounding various policy options: identify public opinion and political will regarding policy options. What information is available from previous committee reports that can inform policy development? No limit on number of references.